Quantcast

Latest Statin Stories

2014-05-13 23:01:37

The Firm is investigating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the statin medication. New York, New York (PRWEB) May 13, 2014 Hundreds of Lipitor lawsuits (http://www.thelipitorlawsuit.com/) filed on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the statin medication continue to move forward in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. According...

2014-05-10 23:01:30

The Firm is evaluating Lipitor lawsuits on behalf of patients whose use of the statin drug allegedly caused Type 2 diabetes. New York, New York (PRWEB) May 10, 2014 Hundreds of Lipitor lawsuits (http://www.thelipitorlawsuit.com/) that claim the statin drug caused patients to suffer Type 2 diabetes continue to move forward in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. Among other things, a Case Management Order issued on April 25, 2014,...

2014-05-06 23:13:03

As lawsuit filings climb, national network of attorneys offers no-cost consultations to consumers over allegations that Lipitor and other statins increase the risk of developing diabetes. San Diego, CA (PRWEB) May 06, 2014 http://www.resource4thepeople.com/defectivedrugs/lipitor-lawsuit.html Resource4thePeople today announced its latest legal update for consumers who are interested in litigation involving allegations that the anti-cholesterol medication Lipitor may cause patients to...

2014-05-06 04:23:22

WILMINGTON, Del., May 6, 2014 /PRNewswire/ -- AstraZeneca (NYSE: AZN) today announced the US Food and Drug Administration (FDA) approved EPANOVA(®) (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500 mg/dL). To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/7192251-astrazeneca-fda-approval EPANOVA is the first FDA approved...

2014-05-02 10:23:15

Johns Hopkins research finds subclinical disease in half of those studied, but specialized imaging needed to detect it Traditional first-line checks of such heart disease risk factors as cholesterol, blood pressure and smoking habits aren’t nearly good enough to identify cardiovascular disease in otherwise healthy, young firefighters, according to results of a small Johns Hopkins study. Previous studies have found that cardiovascular disease accounts for 45 percent of deaths of...

2014-05-02 08:25:43

Data suggest lower risk of major adverse cardiovascular events and death, especially in patients with diabetes or prior coronary heart disease ORLANDO, Fla., May 2, 2014 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced data suggesting that the use of a target low-density lipoprotein...

2014-04-30 23:25:16

Host GJ Reynolds and co-host Neil Haley, The Total Tutor of the SimplyG Radio Show, interviewed Kurt Warner to find out about his latest project First and Goal. Lincoln, NE (PRWEB) April 30, 2014 Host GJ Reynolds and co-host Neil Haley, The Total Tutor of the SimplyG Radio Show, interviewed Kurt Warner to find out about his latest project First and Goal. Reynolds shared, "Kurt you have been such an excellent role model, both on the field and off of it. Thank you!" Warner’s...

2014-04-30 23:05:48

The Charleston-based law firm continues to investigate claims of women who developed Type II diabetes after taking the cholesterol-lowering drug Lipitor as 56 cases are centralized into multidistrict litigation in South Carolina. CHARLESTON, W.Va. (PRWEB) April 30, 2014 The Bell Law Firm’s Charleston Lipitor attorneys are currently investigating injury claims related to the development of Type II diabetes in women who took Lipitor in light of the recent consolidation of 56 similar cases...

2014-04-29 12:34:49

Results presented at the American Academy of Neurology meeting CARLSBAD, Calif., April 29, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today provided an update on both of its ongoing open-label Phase 2 clinical studies of ISIS-SMN(Rx) in infants and children with spinal muscular atrophy (SMA) at the 66(th) American Academy of Neurology (AAN) meeting in Philadelphia, PA. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO Results from Phase 2 study in infants with SMA...

Free Ride? Statin Users Are Consuming More Calories
2014-04-28 13:23:45

Brett Smith for redOrbit.com - Your Universe Online Statins are drugs designed to lower cholesterol in individuals at increased risk for cardiovascular disease, and a new study has suggests that these drugs are giving people a false sense of security. According to the study, published in the journal JAMA Internal Medicine, individuals taking statins between 2009 and 2010 were consuming more calories and fat compared to those who used statins 10 years earlier. "We believe that this is...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related